FOLD (FOLD)
Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for FOLD yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
FOLD has not issued a press release in this window.
SEC filings
All filings →FOLD has not filed an SEC document in this window.
Insider trades
All insider trades →FOLD has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
BlackRock, Inc.$463.1M
32,524,381 sh+25.8%
HBK INVESTMENTS L P$217.2M
15,250,000 sh● NEW
1,373,867 sh-95.2%
VANGUARD GROUP INC$423.0M
29,702,696 sh+0.6%
11,500,000 sh● NEW
Bellevue Group AG$152.9M
10,735,195 sh● NEW
STATE STREET CORP$211.2M
14,833,314 sh+28.3%
5,069,590 sh● NEW
People at FOLD
All people →Quarterly financials
Full financials →Revenue trend
03/25
$11.2M
NI -$21.7M
06/25
$75.3M
NI -$24.4M
09/25
$169.1M
NI $17.3M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.06
Prior: $-0.08
Revenue sparkline